Home | Top News | World | US News | Politics | Economy | Sports | Technology | Science | Lifestyle | People | Recalls

UPDATED: Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium and Hydrochlorothiazide Tablets, USP


Torrent Pharmaceuticals Limited is expanding its voluntary recall from 10 lots of Losartan potassium tablets USP to include 6 lots of Losartan potassium and hydrochlorothiazide tablets, USP, to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. (US Food Recalls) More More

Similar stories

2019 FDA Drug Recalls You Need to Know About - Care2.com

2019 FDA Drug Recalls You Need to Know About  Care2.com

We're only three months into the year, and the FDA has already removed countless drugs, both over-the-counter and pharmaceutical, from the shelves.

Posted on 27 March 2019 | 2:00 am | Google News

Legacy Pharmaceutical Packaging, LLC Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 25mg, 50mg, And 100mg Due to The Detection of Trace Amounts Of N-Nitroso N-Methyl 4-Amino Butyric Acid (NMBA) Impurity Found in The Active Pharmaceutical Ingredient (API) - US Recall News

Legacy Pharmaceutical Packaging, LLC Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 25mg, 50mg, And 100mg Due to The Detection of Trace Amounts Of N-Nitroso N-Methyl 4-Amino Butyric Acid (NMBA) Impurity Found in The Active Pharmaceutical Ingredient (API)  US Recall News

Earth City, MO, Legacy Pharmaceutical Packaging, LLC is recalling 40 repackaged lots of Losartan Tablets USP 25mg, 50mg, and 100mg to the consumer level.

Posted on 15 March 2019 | 2:00 am | Google News

Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 25 mg, 50 mg and 100 mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity found in the Active Pharmaceutical Ingredient (API) - US Recall News

Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 25 mg, 50 mg and 100 mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity found in the Active Pharmaceutical Ingredient (API)  US Recall News

31722-700-90 Losartan Potassium Tablets USP 25 mg 90 LOP17026B Sep-19 31722-700-90 Losartan Potassium Tablets USP 25 mg 90 LOP17050 Sep-19 ...

Posted on 28 February 2019 | 3:00 am | Google News

Detection of Impurity Prompts Company to Recall 1 Lot of Combination Tablets - Pharmacy Times

Detection of Impurity Prompts Company to Recall 1 Lot of Combination Tablets  Pharmacy Times

Macleods Pharmaceuticals Limited has voluntarily recalled 1 lot of Losartan Potassium/Hydrochlorothiazide combination tablets 100mg/25mg to the consumer ...

Posted on 22 February 2019 | 3:00 am | Google News

BLOOD PRESSURE MEDICINE CANCER RISK: More than a dozen blood pressure medications recalled since July - WPXI Pittsburgh

BLOOD PRESSURE MEDICINE CANCER RISK: More than a dozen blood pressure medications recalled since July  WPXI Pittsburgh

PITTSBURGH - Another day, another problem for blood pressure medications, and it's starting to frustrate Cindy Bryan who takes her pills daily. "Even the ...

Posted on 1 February 2019 | 3:00 am | Google News

Six Additional Lots of Losartan Tablets Recalled - Pharmacy Times

Six Additional Lots of Losartan Tablets Recalled  Pharmacy Times

Torrent Pharmaceuticals Limited has expanded its voluntary recall of Losartan potassium tablets USP to include 6 lots of Losartan potassium and ...

Posted on 23 January 2019 | 3:00 am | Google News

Copyright © 2019 LastMinuteStuff.com
Contact info